Medical Doctor Program year 2022 Reported 2019–2022 Source: CMS Open Payments, 2026 publication

Jeffrey Nahmias

Sleep Medicine Summit, NJ Medical Doctor

NPI 1881654036 CMS profile 1270479

1 Springfield Ave, Attn Dr Claire Majisu, Summit, NJ 07901

Open in the dashboard

General payments

$451

37 records reported · program years 2019–2022

Research payments

$0

Paid to them · None reported · program years 2019–2022

Ownership & investment interest

$0

None reported

Through program year 2022, Jeffrey Nahmias of Summit, NJ is reported in the CMS Open Payments database as having received $451 across 37 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 33rd percentile of Sleep Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2022 General $15 1
2021 General $187 16
2020 General $118 9
2019 General $132 11

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jeffrey Nahmias
  • Sleep Medicine median
  • Middle half of Sleep Medicine
  • National median

In program year 2025, general payments to Jeffrey Nahmias were reported at $0. Among 670 Sleep Medicine profiles paid that year, the median was $439 and the middle half received between $127 and $1,274.

Show as a table
Year Jeffrey Nahmias Sleep Medicine median Middle half National median
2019 $132 $185 $66–$736 $163
2020 $118 $149 $46–$504 $114
2021 $187 $191 $62–$750 $132
2022 $15 $246 $92–$972 $149
2023 $0 $321 $119–$1,033 $160
2024 $0 $393 $111–$1,207 $164
2025 $0 $439 $127–$1,274 $169

Breakdown

Who paid General payments · program years 2019–2022
  1. Jazz Pharmaceuticals Inc. $209 17 payments
  2. GlaxoSmithKline, LLC. $191 16 payments
  3. Harmony Biosciences LLC $28 2 payments
  4. Merck Sharp & Dohme Corporation $14 1 payment
  5. Aytu BioScience, Inc $11 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2022
  1. Food and Beverage $451 37 payments
Products named General payments · program years 2019–2022
  1. TRELEGY ELLIPTA $143 12 payments
  2. XYREM $93 8 payments
  3. SUNOSI Pain $40 3 payments
  4. SUNOSI Neurology $38 3 payments
  5. XYWAV $38 3 payments
  6. Wakix $28 2 payments
  7. NUCALA $26 2 payments
  8. ANORO ELLIPTA $21 2 payments
  9. BELSOMRA $14 1 payment
  10. Natesto $11 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

37 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sleep Medicine in New Jersey

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2022

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record